pSivida Corp. (NASDAQ:PSDV) shares rose 2.4% during trading on Monday . The company traded as high as $3.94 and last traded at $3.91, with a volume of 57,321 shares. The stock had previously closed at $3.82.

Separately, FBR & Co reissued a “buy” rating and issued a $7.00 price target on shares of pSivida Corp. in a report on Thursday, June 23rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $7.00.

The stock’s market cap is $133.61 million. The stock has a 50 day moving average of $3.28 and a 200 day moving average of $3.10.

pSivida Corp. (NASDAQ:PSDV) last announced its quarterly earnings data on Thursday, May 5th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.05. Equities analysts predict that pSivida Corp. will post ($0.62) earnings per share for the current fiscal year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.